Approved Publications:
- Elhassan, E.A.E. et al. (2025) “Characterization of Monogenic Kidney Disease in Older Patients With CKD,” Kidney International Reports, 10(7), pp. 2140–2152. Available at: https://doi.org/https://doi.org/10.1016/j.ekir.2025.04.017.
- Klapperich, A. et al. (2026) “Severe Prenatal Presentation of Adenylosuccinate Lyase Deficiency Caused by a Synonymous ADSL Variant Inducing Aberrant Splicing.,” Prenatal diagnosis [Preprint]. Available at: https://doi.org/10.1002/pd.70087.
- Klassen RA, Chytilova S, Arzhanov I, et al (2025) Integrated multi-omics profiling uncovers miRNA-guided regulatory networks after spinal cord injury in rats. Mol Ther Nucleic Acids 36:. https://doi.org/10.1016/j.omtn.2025.102746
- Kmoch S, Živná M, Dvela-Levitt M, et al (2025) Expanded View of the Pathophysiology of Fabry Disease. Nephron 149:620–624. https://doi.org/10.1159/000546555
- Kraus, D. et al. (2026) “Regulation of Embryonic Wound Healing by Matrix Metalloproteinases in Xenopus laevis Tailbud Stage.,” Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 34(1), p. e70134. Available at: https://doi.org/10.1111/wrr.70134.
- Mušálková, D. et al. (2026) “Plasma Metabolites Associated with CKD Stage in Autosomal Dominant Tubulointerstitial Kidney Disease,” Kidney360, 7(2). Available at: https://journals.lww.com/kidney360/fulltext/2026/02000/plasma_metabolites_associated_with_ckd_stage_in.14.aspx.
- Veselá K, Tatar A, Kejík Z, et al (2025) Ruthenium-enhanced curcumin derivatives target tumor growth and cancer-related inflammation in head and neck cancer models. Front Oncol 15:1708944. https://doi.org/10.3389/fonc.2025.1708944
- Veselá K, Tatar A, Kejík Z, et al (2026) Targeting tumors and inflammation: A quinoline–chalcone ruthenium complex with therapeutic promise. Biomed Pharmacother 194:118930. https://doi.org/https://doi.org/10.1016/j.biopha.2025.118930
Unpublished:
- Cano-Estrada, C. et al. (2026) “Physiological cell culture media alter nucleotide metabolism in T lymphocytes and increase their sensitivity to methotrexate.” (preprint)
- Coci EG, Gertzen CGW, Millan PC, et al (2025) DDX3X syndrome: a multicenter genotype-phenotype study. DOI:10.21203/rs.3.rs-7842722/v1 (preprint)
- Kidd KO, Williams AH, Elhassan EAE, et al (2025) An Observational Study of SGLT2 Inhibitors and Their Use in Autosomal Dominant Tubulointerstitial Kidney Disease. Res Sq. https://doi.org/10.21203/rs.3.rs-7482366/v1 (preprint)
- Vrbacká A, Přistoupilová A, Kidd KO, et al (2025) Long-Read Sequencing of the MUC1 VNTR: Genomic Variation, Mutational Landscape, and Its Impact on ADTKD Diagnosis and Progression. bioRxiv 2025.09.06.673538. https://doi.org/10.1101/2025.09.06.673538 (preprint)